← Leaderboards
Yvonne J Rosenberg
Procell Corporation
$9,253,501
Attributed
$9,253,501
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2007–21$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$9,253,501 · 11
By mechanism
R44$6,305,700 · 3
R43$1,496,034 · 7
U44$1,451,767 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseProductionExhibitsMacacaSmall Business Innovation Research GrantRecombinantsGrantPlantsAntibodiesPreventDrug KineticsEnzymesOrganophosphatesCessation Of LifeNeurotoxicityToxic EffectBloodDoseInsecticidesPublic Health RelevanceInjection Of Therapeutic AgentNeutralizing AntibodyBaseInnovation
Grant awards (19)
Development of a handheld PEST-pen device for the rapid detection of organophosphate insecticides on food and clothing$515,084
R44 · FY2021 · ES · contact PI
Development of a handheld PEST-pen device for the rapid detection of organophosphate insecticides on food and clothing$705,843
R44 · FY2020 · ES · contact PI
Zwitterionic oxime (RS194B) to reverse advanced symptoms and lethality of organophosphate pesticide exposure$224,858
R43 · FY2018 · NS · contact PI
Development of a handheld PEST-pen device for the rapid detection of organophosphate insecticides on food and clothing$149,980
R43 · FY2018 · ES · contact PI
Plant-derived HIV neutralizing mAbs for passive immunotherapy in newborn macaques$1,000,000
R44 · FY2017 · AI · contact PI
Plant-derived HIV neutralizing mAbs for passive immunotherapy in newborn macaques$1,000,000
R44 · FY2016 · AI · contact PI
Augmentation of HIV Env vaccine efficacy by DC targeting$224,813
R43 · FY2015 · AI · contact PI
Efficacy and Safety of an Aerosolized Recombinant Butyrylcholinesterase Pretreatm$5,000
R44 · FY2015 · NS · contact PI
Efficacy and Safety of an Aerosolized Recombinant Butyrylcholinesterase Pretreatm$858,920
R44 · FY2014 · NS · contact PI
Efficacy and Safety of an Aerosolized Recombinant Butyrylcholinesterase Pretreatm$753,417
R44 · FY2013 · NS · contact PI
Passive immunotherapy using plant-derived broadly HIV-1 neutralizing MAbs to prev$741,390
R44 · FY2012 · AI · contact PI
Aerosol Delivery of a Recombinant Butyrylcholinesterase "BioShield" to Protect Ag$618,077
U44 · FY2012 · NS · contact PI
Passive immunotherapy using plant-derived broadly HIV-1 neutralizing MAbs to prev$726,046
R44 · FY2011 · AI · contact PI
Aerosol Delivery of a Recombinant Butyrylcholinesterase "BioShield" to Protect Ag$545,727
U44 · FY2010 · NS · contact PI
Aerosol Delivery of a Recombinant Butyrylcholinesterase "BioShield" to Protect Ag$287,963
U44 · FY2009 · NS · contact PI
Passive immunotherapy using plant-derived broadly HIV-1 neutralizing MAbs to prev$256,501
R43 · FY2009 · AI · contact PI
Induction of 2G12 neutralizing antibody by plant-derived HIVgp145$222,753
R43 · FY2007 · AI · contact PI
A Plant-Derived Recombinant Bioscavenger to Prevent Insecticide Neurotoxicity$169,584
R43 · FY2007 · NS · contact PI
Immunogenicity of plant-expressed p55 Gag and gp120$247,545
R43 · FY2003 · AI